top of page
Intellectual Property Portfolio
Composition of Matter
Beck TC, Morningstar J, Norris RA. Inhibitors of MEK/ERK and Methods of Use Thereof. Provisional: 112746-103298 (P20115).
Method of Use
Beck TC, Morningstar J, Norris RA. Treatment of Cutaneous Fibroproliferative Diseases with Locally Administered MEK1 Inhibitors. Provisional: 112746-109385 (P2308P). Filed June 16, 2023.
Composition of Matter
Beck TC, Morningstar J, Dix TA, Norris RA. Opioid Agonists and Methods of Use Thereof. Provisional: 206085-0109-P1US. Filed December 15, 2022.
bottom of page